Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON52395Completed
Open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Leiden University Medical Center. Primary endpoint: Successful withdrawal from thyroid medication at 52 weeks. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON52395.